Blood test offers insight into Alzheimer’s stage and severity A newly developed blood test for Alzheimer’s disease not only helps with the diagnosis of the neurodegenerative disorder, but also…
MHRA greenlights donanemab for early stage Alzheimer’s disease The Medicines and Healthcare products Regulatory Agency (MHRA) has today, October 23, 2024, approved a license for the medicine donanemab…
